DHG Stock Overview
Engages in the manufacture and sale of pharmaceutical products primarily in Vietnam. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
DHG Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫99,600.00 |
| 52 Week High | ₫125,900.00 |
| 52 Week Low | ₫95,000.00 |
| Beta | 0.51 |
| 11 Month Change | -5.59% |
| 3 Month Change | -6.83% |
| 1 Year Change | -3.30% |
| 33 Year Change | 0% |
| 5 Year Change | 6.64% |
| Change since IPO | 142.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| DHG | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -3.0% | 0.1% | -2.3% |
| 1Y | -3.3% | 19.4% | 7.2% |
Return vs Industry: DHG underperformed the VN Pharmaceuticals industry which returned 19.4% over the past year.
Return vs Market: DHG underperformed the VN Market which returned 7.2% over the past year.
Price Volatility
| DHG volatility | |
|---|---|
| DHG Average Weekly Movement | 1.2% |
| Pharmaceuticals Industry Average Movement | 3.4% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in VN Market | 6.5% |
| 10% least volatile stocks in VN Market | 1.8% |
Stable Share Price: DHG has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: DHG's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 2,796 | Toshiyuki Ishii | www.dhgpharma.com.vn |
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products primarily in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health supplements and pharmaceuticals cosmeceuticals.
DHG Pharmaceutical Joint Stock Company Fundamentals Summary
| DHG fundamental statistics | |
|---|---|
| Market cap | ₫13.02t |
| Earnings (TTM) | ₫804.09b |
| Revenue (TTM) | ₫4.96t |
16.2x
P/E Ratio2.6x
P/S RatioIs DHG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHG income statement (TTM) | |
|---|---|
| Revenue | ₫4.96t |
| Cost of Revenue | ₫2.84t |
| Gross Profit | ₫2.12t |
| Other Expenses | ₫1.32t |
| Earnings | ₫804.09b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.15k |
| Gross Margin | 42.82% |
| Net Profit Margin | 16.21% |
| Debt/Equity Ratio | 26.2% |
How did DHG perform over the long term?
See historical performance and comparison